SHANDONG BOAN BIOTECH.H 1 (UJ9) — Cash Flow Reinvestment Rate

Latest as of December 2025: 4.22x

SHANDONG BOAN BIOTECH.H 1 (UJ9) has a Cash Flow Reinvestment Rate of 4.22x as of December 2025, reinvesting €274.05 Million (capex €274.05 Million ) from operating cash flow of €64.89 Million. See SHANDONG BOAN BIOTECH.H 1 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

4.22x

(Capex + Investments) / Operating CF

Total Reinvested

€274.05 Million

Capex + Investments

Operating Cash Flow

€64.89 Million

EUR

Capital Expenditures

€274.05 Million

EUR

SHANDONG BOAN BIOTECH.H 1 Cash Flow Reinvestment Rate (2025–2025)

Historical reinvestment intensity for SHANDONG BOAN BIOTECH.H 1 across 1 annual periods. For the full cash flow conversion analysis, see UJ9 operating cash flow.

Annual Cash Flow Reinvestment Rate for SHANDONG BOAN BIOTECH.H 1 (2025–2025)

Year-by-year capital reinvestment analysis for SHANDONG BOAN BIOTECH.H 1. See financial agility of SHANDONG BOAN BIOTECH.H 1 to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (EUR)	Operating CF	Capex	YoY Change
2025	4.22x	€274.05 Million	€64.89 Million	€274.05 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow